NCT06757504: Evaluate the Efficacy and Safety of TTYP01 Tablets in Adolescents and Children With ASD
- State
- Under way
- Phase
- Phase 2
- People
- 150 planned
- Started
- 13 Jan 2025
- Primary completion
- 6 Feb 2026
- Arms
- TTYP01 low-dose group, TTYP01 high-dose group
- Results
- None posted
- 3 Jan 2025: Trial registered
- 13 Jan 2025: Trial started